CLOV vs INO · rev $1.37B vs rev $217.8K
Clover Health Investments Corp (CLOV) versus Inovio Pharmaceuticals Inc (INO) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Inovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported INO revenue for 2024-12-31 was $217.8K. Net income was -$107.3M. Revenue was down 73.8% from 2023-12-31 to 2024-12-31. INO currently screens at market cap $88.0M.
CLOV currently screens at market cap $1.55B. INO currently screens at market cap $88.0M.
Not investment advice. Open the CLOV and INO stock pages for the full models.
Not investment advice.